|

CX-801 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • CytomX Therapeutics1

Indications

Englewood, Colorado1 trial

First In Human Study of CX-801 in Advanced Solid Tumors

The Melanoma and Skin Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.